[1] |
World Health Organization . Global tuberculosis report 2017. Geneva: World Health Organization, 2017.
|
[2] |
中华人民共和国国务院人口普查办公室,中华人民共和国国家统计局人口和就业统计司. 中国2010 年人口普查资料(上、中、下册).北京: 中国统计出版社, 2012.
|
[3] |
裴宁, 李波, 曹文利 , 等. 老年肺结核患者的耐药性分析. 中国防痨杂志, 2017,39(9):985-989.
doi: 10.3969/j.issn.1000-6621.2017.09.017
URL
|
[4] |
张玉, 叶建君, 杨成凤 , 等. 2006—2015年湖北省老年肺结核疫情特征及变化趋势分析. 中国防痨杂志, 2017,39(2):213-216.
doi: 10.3969/j.issn.1000-6621.2017.02.021
URL
|
[5] |
全国第五次结核病流行病学抽样调查技术指导组, 全国第五次结核病流行病学抽样调查办公室. 2010年全国第五次结核病流行病学抽样调查报告. 中国防痨杂志, 2012,34(8):485-508.
|
[6] |
中华人民共和国卫生部. WS 288—2008 肺结核诊断标准.北京: 人民卫生出版社, 2008.
|
[7] |
中华人民共和国卫生部疾病预防控制局,中华人民共和国卫生部医政司,中国疾病预防控制中心. 中国结核病防治规划实施工作指南(2008年版).北京: 中国协和医科大学出版社, 2009: 52-70.
|
[8] |
中华医学会. 临床诊疗指南:结核病分册.北京: 人民卫生出版社, 2005.
|
[9] |
Hauer B, Brodhun B, Altmann D , et al. Tuberculosis in the elderly in Germany. Eur Respir J, 2011,38(2):467-470.
doi: 10.1183/09031936.00199910
URL
pmid: 21804163
|
[10] |
Ananthakrishnan R, Kumar K, Ganesh M , et al. The profile and treatment outcomes of the older (aged 60 years and above) tuberculosis patients in Tamilnadu, South India. PLoS One, 2013,8(7):e67288.
doi: 10.1371/journal.pone.0067288
URL
|
[11] |
Touré NO, Dia Kane Y, Diatta A , et al. Tuberculosis in elderly persons. Rev Mal Respir, 2010,27(9):1062-1068.
doi: 10.1016/j.rmr.2010.04.017
URL
|
[12] |
Oshi DC, Oshi SN, Alobu I , et al. Profile and treatment outcomes of tuberculosis in the elderly in southeastern Nigeria, 2011-2012. PLoS One, 2014,9(11):e111910.
doi: 10.1371/journal.pone.0111910
URL
|
[13] |
Ncube RT, Takarinda KC, Zishiri C , et al. Age-stratified tuberculosis treatment outcomes in Zimbabwe: are we paying attention to the most vulnerable? Public Health Action, 2017,7(3):212-217.
doi: 10.5588/pha.17.0024
URL
|
[14] |
Gavazzi G, Herrmann F, Krause KH . Aging and infectious diseases in the developing world. Clin Infect Dis, 2004,39(1):83-91.
doi: 10.1086/421559
URL
pmid: 15206058
|
[15] |
Walubo A, Chan K, Woo J , et al. The disposition of antituberculous drugs in plasma of elderly patients. I. Isoniazid and hydrazine metabolite. Methods Find Exp Clin Pharmacol, 1991,13(8):545-550.
|
[16] |
吴妍, 李琦 . 老年肺结核的诊治现状与进展. 中国防痨杂志, 2015,37(9):975-978.
doi: 10.3969/j.issn.1000-6621.2015.09.012
URL
|
[17] |
李剑波, 张丽祥, 陆华 . 肺结核患者不同年龄组发生药物不良反应的对比研究. 中国防痨杂志, 2016,38(12):1109-1114.
doi: 10.3969/j.issn.1000-6621.2016.12.019
URL
|
[18] |
Huang YS, Chern HD, Su WJ , et al. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis. Hepatology, 2002,35(4):883-889.
doi: 10.1053/jhep.2002.32102
URL
|
[19] |
Teleman MD, Chee CB, Earnest A , et al. Hepatotoxicity of tuberculosis chemotherapy under general programme conditions in Singapore. Int J Tuberc Lung Dis, 2002,6(8):699-705.
doi: 10.4028/www.scientific.net/MSF.264-268.1073
URL
pmid: 12150482
|
[20] |
Righi E, Della Siega P, Merelli M , et al. Comparison of clinical characteristics of tuberculosis between two age groups at an Italian Tertiary Hospital. Infection, 2015,43(3):361-366.
doi: 10.1007/s15010-015-0765-y
URL
|
[21] |
Velayutham BR, Nair D, Chandrasekaran V , et al. Profile and response to anti-tuberculosis treatment among elderly tuberculosis patients treated under the TB Control programme in South India. PLoS One, 2014,9(3):e88045.
doi: 10.1371/journal.pone.0088045
URL
|
[22] |
Pratt RH, Winston CA, Kammerer JS , et al. Tuberculosis in older adults in the United States, 1993—2008. J Am Geriatr Soc, 2011,59(5):851-857.
doi: 10.1111/j.1532-5415.2011.03369.x
URL
pmid: 21517786
|
[23] |
Patra S, Lukhmana S, Tayler Smith K , et al. Profile and treatment outcomes of elderly patients with tuberculosis in Delhi, India: implications for their management. Trans R Soc Trop Med Hyg, 2013,107(12):763-768.
doi: 10.1093/trstmh/trt094
URL
|